nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—ABCB1—Lisinopril—dilated cardiomyopathy	0.112	0.532	CbGbCtD
Ergotamine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0986	0.468	CbGbCtD
Ergotamine—HTR2B—cardial valve—dilated cardiomyopathy	0.0799	0.503	CbGeAlD
Ergotamine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0279	0.176	CbGeAlD
Ergotamine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0173	0.109	CbGeAlD
Ergotamine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0168	0.106	CbGeAlD
Ergotamine—Lisuride—ADRB1—dilated cardiomyopathy	0.00671	0.519	CrCbGaD
Ergotamine—Bromocriptine—ADRB1—dilated cardiomyopathy	0.00621	0.481	CrCbGaD
Ergotamine—HTR2B—heart—dilated cardiomyopathy	0.00442	0.0278	CbGeAlD
Ergotamine—ADRA1A—heart—dilated cardiomyopathy	0.00365	0.0229	CbGeAlD
Ergotamine—ADRA2A—heart—dilated cardiomyopathy	0.00277	0.0174	CbGeAlD
Ergotamine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00237	0.0149	CbGeAlD
Ergotamine—HTR2A—heart—dilated cardiomyopathy	0.00236	0.0148	CbGeAlD
Ergotamine—ABCB1—heart—dilated cardiomyopathy	0.00155	0.00972	CbGeAlD
Ergotamine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000158	0.000257	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000158	0.000256	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000158	0.000255	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000157	0.000254	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000156	0.000252	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000156	0.000252	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000155	0.000251	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000154	0.00025	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000154	0.000249	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000153	0.000248	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000153	0.000247	CbGpPWpGaD
Ergotamine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000152	0.000246	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000152	0.000246	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000152	0.000246	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000151	0.000245	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000151	0.000245	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000151	0.000244	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00015	0.000243	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000149	0.000241	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000148	0.000239	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000147	0.000239	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000147	0.000239	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000147	0.000239	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000147	0.000239	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000147	0.000238	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	0.000146	0.000236	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000145	0.000235	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000145	0.000234	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000145	0.000234	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000144	0.000234	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000144	0.000233	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000144	0.000233	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000143	0.000231	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000141	0.000229	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000141	0.000229	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00014	0.000228	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000139	0.000226	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000138	0.000223	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AGT—dilated cardiomyopathy	0.000137	0.000223	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000137	0.000223	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000137	0.000222	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000137	0.000222	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000137	0.000222	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000136	0.00022	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000135	0.000219	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000135	0.000219	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000134	0.000217	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000134	0.000217	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000216	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000216	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000133	0.000215	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000132	0.000214	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000131	0.000213	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00013	0.00021	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00013	0.00021	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000129	0.000209	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000129	0.000209	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000129	0.000209	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000128	0.000208	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000128	0.000208	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000128	0.000207	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000128	0.000207	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000128	0.000207	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000127	0.000206	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000126	0.000203	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000125	0.000202	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000125	0.000202	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000124	0.0002	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000123	0.0002	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000123	0.000199	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000123	0.000199	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000123	0.000198	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000122	0.000198	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000122	0.000198	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000122	0.000198	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000122	0.000197	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000122	0.000197	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00012	0.000194	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000119	0.000193	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000119	0.000193	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000119	0.000192	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000118	0.000191	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000117	0.00019	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000117	0.00019	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000117	0.00019	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000117	0.00019	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.000189	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000116	0.000187	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000116	0.000187	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000116	0.000187	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000115	0.000186	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000115	0.000186	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000114	0.000184	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000114	0.000184	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000114	0.000184	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000113	0.000184	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000113	0.000183	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000113	0.000183	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000112	0.000181	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000112	0.000181	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000112	0.000181	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000111	0.00018	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000111	0.00018	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000111	0.000179	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00011	0.000178	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00011	0.000178	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00011	0.000178	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000109	0.000177	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000109	0.000176	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000109	0.000176	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000108	0.000175	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000108	0.000175	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000108	0.000174	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000107	0.000174	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000107	0.000173	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000106	0.000172	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000106	0.000171	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000105	0.00017	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000104	0.000169	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000103	0.000167	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000103	0.000167	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000166	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000102	0.000165	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000102	0.000165	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000102	0.000164	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000101	0.000164	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000101	0.000164	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000101	0.000164	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000101	0.000164	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000101	0.000163	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.99e-05	0.000162	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.95e-05	0.000161	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.93e-05	0.000161	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.88e-05	0.00016	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.83e-05	0.000159	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.78e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	9.75e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.71e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.68e-05	0.000157	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	9.55e-05	0.000155	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—RAF1—dilated cardiomyopathy	9.54e-05	0.000155	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.41e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.39e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.37e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.37e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.32e-05	0.000151	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	9.32e-05	0.000151	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.25e-05	0.00015	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.24e-05	0.00015	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.24e-05	0.00015	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	9.12e-05	0.000148	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.09e-05	0.000147	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.99e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	8.97e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.92e-05	0.000145	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.67e-05	0.00014	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	8.57e-05	0.000139	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.53e-05	0.000138	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.46e-05	0.000137	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.36e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	8.35e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.34e-05	0.000135	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.23e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.17e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.12e-05	0.000132	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.1e-05	0.000131	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.1e-05	0.000131	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.05e-05	0.00013	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.01e-05	0.00013	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	7.98e-05	0.000129	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.93e-05	0.000128	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.78e-05	0.000126	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.76e-05	0.000126	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.67e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	7.54e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.51e-05	0.000122	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	7.45e-05	0.000121	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.37e-05	0.000119	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.35e-05	0.000119	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.28e-05	0.000118	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	7.26e-05	0.000118	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	7.24e-05	0.000117	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	7.2e-05	0.000117	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.17e-05	0.000116	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.07e-05	0.000115	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.05e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.96e-05	0.000113	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	6.95e-05	0.000113	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	6.94e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	6.93e-05	0.000112	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	6.92e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.91e-05	0.000112	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.91e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.81e-05	0.00011	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.69e-05	0.000108	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	6.62e-05	0.000107	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EGFR—dilated cardiomyopathy	6.54e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	6.53e-05	0.000106	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	6.47e-05	0.000105	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.43e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.42e-05	0.000104	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.39e-05	0.000103	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.33e-05	0.000103	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.33e-05	0.000103	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.28e-05	0.000102	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.15e-05	9.97e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.1e-05	9.88e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	6e-05	9.73e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	5.95e-05	9.63e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.88e-05	9.52e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.8e-05	9.4e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.72e-05	9.26e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.6e-05	9.07e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.57e-05	9.02e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	5.54e-05	8.96e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	5.46e-05	8.85e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.33e-05	8.64e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	5.15e-05	8.34e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.02e-05	8.13e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	5e-05	8.09e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.92e-05	7.96e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.84e-05	7.84e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.82e-05	7.81e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	4.8e-05	7.77e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.74e-05	7.67e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	4.59e-05	7.44e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.52e-05	7.32e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	4.43e-05	7.18e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.4e-05	7.13e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.34e-05	7.03e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.24e-05	6.86e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.17e-05	6.75e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.11e-05	6.66e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.08e-05	6.61e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.08e-05	6.61e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.01e-05	6.49e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	3.8e-05	6.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.79e-05	6.14e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.61e-05	5.84e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.43e-05	5.55e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.31e-05	5.36e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.29e-05	5.33e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.17e-05	5.14e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.15e-05	5.1e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.09e-05	5.01e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.9e-05	4.7e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.86e-05	4.63e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.8e-05	4.53e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.78e-05	4.51e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.6e-05	4.21e-05	CbGpPWpGaD
